Trial
NCT00831441
Phase III Acute Coronary Syndrome
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Bristol-Myers Squibb
Collaborators
Pfizer; Duke Clinical Research Institute
Condition
Acute Coronary Syndrome
Intervention
Apixaban
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-01-27